Allyx Therapeutics to Present Phase 1 Data for Lead Compound ALX-001 at the 16th Clinical Trials on Alzheimer's Disease Meeting
19 oct. 2023 16h05 HE
|
Allyx Therapeutics Inc.
Allyx Therapeutics presents Phase 1 ALX-001 data at CTAD. ALX-001 is a small molecule with unique mechanism at mGluR5 to protect and preserve synapses.
Neurovascular Devices Market - Global Forecast to 2028: Increasing Incidence of Ischemic Stroke and Cerebral Aneurysms Boosts Demand
18 oct. 2023 05h48 HE
|
Research and Markets
Dublin, Oct. 18, 2023 (GLOBE NEWSWIRE) -- The "Neurovascular Devices Market by Disease Pathology (Cerebral Ameurysm (Embolic coils), Ischemic Stroke (Clot retrievers, Aspiration, Microcatheters),...
Sosei Heptares and PharmEnable Therapeutics Expand Drug Discovery Collaboration
10 oct. 2023 02h30 HE
|
Sosei Group Corporation
The collaboration combines Sosei Heptares’ leading structure-based drug design platform with PharmEnable’s advanced artificial intelligence-enabled platform for designing high quality novel chemistry...
"Advancements in Acute Ischemic Stroke Therapeutics Market CAGR of 4.6 %: A Ray of Hope for Stroke Patients", Says Market.us
25 sept. 2023 09h03 HE
|
Market.Us
New York, Sept. 25, 2023 (GLOBE NEWSWIRE) -- According to a recent report by Market.us, the Global Acute Ischemic Stroke Therapeutics Market size is expected to be worth around USD 14.0 Billion by...
PET-CT Scanner Devices Market to Exceed USD 310.4 million by 2031, Expanding at a CAGR of 3.1% Says, Transparency Market Research
20 sept. 2023 12h30 HE
|
Transparency Market Research
Wilmington, Delaware, United States, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global PET-CT scanner devices market is projected to flourish at a CAGR of 3.1% from...
STIMVIA Unveils Innovative Solution to Transform CNS Disorder Treatments at TechCrunch Disrupt 2023
20 sept. 2023 12h00 HE
|
STIMVIA s.r.o.
SAN FRANCISCO, Sept. 20, 2023 (GLOBE NEWSWIRE) -- STIMVIA, a pioneer medical technology company, introduces an effective non-invasive neuromodulation treatment, URIS®, addressing deep brain...
AB Science fait une mise au point sur le calendrier de l’EMA concernant l'examen de la demande d'autorisation de mise sur le marché du masitinib dans la SLA
18 sept. 2023 12h05 HE
|
AB Science
COMMUNIQUE DE PRESSE AB SCIENCE FAIT LE POINT SUR LE CALENDRIER DE L'AGENCE EUROPÉENNE DES MÉDICAMENTS CONCERNANT L'EXAMEN DE LA DEMANDE D'AUTORISATION DE MISE SUR LE MARCHÉ DU MASITINIB DANS LA...
AB Science provides an update on the EMA timetable for examination of the masitinib marketing authorization application in ALS
18 sept. 2023 12h05 HE
|
AB Science
PRESS RELEASE AB SCIENCE PROVIDES AN UPDATE ON THE EUROPEAN MEDICINES AGENCY'S TIMETABLE FOR EXAMINATION OF THE MARKETING AUTHORIZATION APPLICATION OF MASITINIB IN AMYOTROPHIC LATERAL SCLEROSIS ...
Key Competitors like Medtronic and Stryker Drive Growth in the Global Intracranial Aneurysm Market, Valued at $1.2 Billion in 2022
14 sept. 2023 06h23 HE
|
Research and Markets
Dublin, Sept. 14, 2023 (GLOBE NEWSWIRE) -- The "Intracranial Aneurysm - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The Global Intracranial...
Inaugural World Hydrocephalus Day
07 sept. 2023 08h40 HE
|
Hydrocephalus Association
Bethesda, MD, Sept. 07, 2023 (GLOBE NEWSWIRE) -- On September 20, 2023, the world will come together to observe the inaugural World Hydrocephalus Day, a day dedicated to raising awareness about...